Literature DB >> 7835572

Role of luminal ammonia in the development of gastropathy and hypergastrinemia in the rat.

L M Lichtenberger1, E J Dial, J J Romero, J Lechago, L A Jarboe, M M Wolfe.   

Abstract

BACKGROUND/AIMS: Chronic infection with Helicobacter pylori causes persistent elevations in gastric juice ammonia levels. Thus, we studied the effects of experimentally induced increases in gastric juice ammonia levels on gastric structure and function and gastrin homeostasis.
METHODS: Rats were fed either normal chow or the diet supplemented (20 g/dL) with ammonium or sodium acetate.
RESULTS: Long-term dietary ammonium loading for 2 weeks or longer resulted in a 1.5-2-fold increase in the weight and mucosal thickness of the stomach and proximal duodenum with evidence of mild gastritis and enterochromaffinlike cell hyperplasia. The ammonium-containing diet also induced a significant 2-3-fold increase in both circulating gastrin levels of fed rats and an increase in the postprandial gastrin responses over control values. Antral gastrin levels were also markedly elevated by long-term ingestion of the test diet, which was increased 3-4-fold over control values in fasted animals and less so after meal stimulation. Consistent with these findings, gastrin-specific messenger RNA was increased 2.5-3-fold in the antrum of ammonium fed rats, whereas actin-specific messenger RNA was not affected or decreased. Animals fed a diet supplemented with 20 g/dL sodium acetate sustained modest increases in mucosal thickness and serum and antral gastrin concentration, suggesting that nonspecific gastric injury and inflammation is also a factor that influences G-cell function.
CONCLUSIONS: Long-term exposure of the antral mucosa to elevated levels of ammonia in the gastric juice in the presence of gastritis, conditions similar to that occurring in subjects infected with H. pylori, seem to be causative factors in the development of G-cell hyperfunction.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7835572     DOI: 10.1016/0016-5085(95)90056-x

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  10 in total

1.  Effects of Helicobacter pylori infection on gastric acid secretion and serum gastrin levels in Mongolian gerbils.

Authors:  M Takashima; T Furuta; H Hanai; H Sugimura; E Kaneko
Journal:  Gut       Date:  2001-06       Impact factor: 23.059

2.  Helicobacter felis infection is associated with lymphoid follicular hyperplasia and mild gastritis but normal gastric secretory function in cats.

Authors:  K W Simpson; D Strauss-Ayali; E Scanziani; R K Straubinger; P L McDonough; A F Straubinger; Y F Chang; C Domeneghini; N Arebi; J Calam
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

3.  Preclinical pharmacology of lumiracoxib: a novel selective inhibitor of cyclooxygenase-2.

Authors:  Ronald Esser; Carol Berry; Zhengming Du; Janet Dawson; Alyson Fox; Roger A Fujimoto; William Haston; Earl F Kimble; Julie Koehler; Jane Peppard; Elizabeth Quadros; Joseph Quintavalla; Karen Toscano; Laszlo Urban; John van Duzer; Xiaoli Zhang; Siyuan Zhou; Paul J Marshall
Journal:  Br J Pharmacol       Date:  2005-02       Impact factor: 8.739

4.  N-methyl D-aspartate channels link ammonia and epithelial cell death mechanisms in Helicobacter pylori Infection.

Authors:  Ji Hye Seo; James G Fox; Richard M Peek; Susan J Hagen
Journal:  Gastroenterology       Date:  2011-09-16       Impact factor: 22.682

5.  Role of apoptosis induced by Helicobacter pylori infection in the development of duodenal ulcer.

Authors:  K Kohda; K Tanaka; Y Aiba; M Yasuda; T Miwa; Y Koga
Journal:  Gut       Date:  1999-04       Impact factor: 23.059

6.  Altered gastrin regulation in mice infected with Helicobacter felis.

Authors:  E J Dial; L R Hall; J J Romero; J Lechago; J G Fox; L M Lichtenberger
Journal:  Dig Dis Sci       Date:  2000-07       Impact factor: 3.199

Review 7.  Helicobacter pylori eradication to prevent gastric cancer: underlying molecular and cellular mechanisms.

Authors:  Shingo Tsuji; Masahiko Tsujii; Hiroaki Murata; Tsutomu Nishida; Masato Komori; Masakazu Yasumaru; Shuji Ishii; Yoshiaki Sasayama; Sunao Kawano; Norio Hayashi
Journal:  World J Gastroenterol       Date:  2006-03-21       Impact factor: 5.742

Review 8.  Determining small bowel integrity following drug treatment.

Authors:  Simon Smale; Ingvar Bjarnason
Journal:  Br J Clin Pharmacol       Date:  2003-09       Impact factor: 4.335

Review 9.  Pharmacology, safety, efficacy and clinical uses of the COX-2 inhibitor robenacoxib.

Authors:  Peter Lees; Pierre-Louis Toutain; Jonathan Elliott; Jerome M Giraudel; Ludovic Pelligand; Jonathan N King
Journal:  J Vet Pharmacol Ther       Date:  2022-04-22       Impact factor: 1.567

10.  Helicobacter pylori-Induced HB-EGF Upregulates Gastrin Expression via the EGF Receptor, C-Raf, Mek1, and Erk2 in the MAPK Pathway.

Authors:  Niluka Gunawardhana; Sungil Jang; Yun Hui Choi; Youngmin A Hong; Yeong-Eui Jeon; Aeryun Kim; Hanfu Su; Ji-Hye Kim; Yun-Jung Yoo; D Scott Merrell; Jinmoon Kim; Jeong-Heon Cha
Journal:  Front Cell Infect Microbiol       Date:  2018-01-15       Impact factor: 5.293

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.